FindTrial
Sign In

Observational study on drug intervention for hyperlipidemia

Observational study on drug intervention for hyperlipidemia in patients with premature cardiovascular and cerebrovascular diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115378
Enrollment
Unknown
Registered
2025-12-25
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular and cerebrovascular diseases

Interventions

Observation group:N/A

Sponsors

Children's Hospital,Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 50 Years

Inclusion criteria

Inclusion criteria: 1. Age of initial diagnosis of coronary heart disease and/or cerebrovascular disease:Male <45 years old;female <50 years old; 2. Meet the diagnostic criteria for coronary heart disease and/or cerebrovascular disease; 3. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with other metabolic diseases or uncontrolled diabetes; 2. Patients with genetic diseases; 3. Ethical and legal: Refuse or inability to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Biochemical indicators;Risk gene;—

Countries

China

Contacts

Public ContactZou Chaochun

Children's Hospital,Zhejiang University School of Medicine

15067123060@163.com+86 571 8667 0072

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026